Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Therapeutics and Clinical Risk Management|March 24, 2021
Polycythemia Vera (PV): Update on Emerging Treatment OptionsGiulia Benevolo, Francesco Vassallo, Irene Urbino, et al.Medicina (Kaunas, Lithuania)|October 23, 2021
Philadelphia-Negative MPN: A Molecular Journey, from Hematopoietic Stem Cell to Clinical FeaturesValentina Giai, Carolina Secreto, Roberto Freilone, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2016
Anemia in the Elderly: not Always what it SeemsMarco Cerrano, Elena Crisà, Valentina Giai, et al.Journal of Biotechnology and Biomedicine|January 16, 2023
Hematopoietic Stem Cells (HSC) and Granulocyte Macrophage Progenitors (GMP) are the Oxidative Stress Targets in Low/Intermediate-1 Risk Myelodysplastic SyndromesValentina Giai, Thea Bensi, Claudia Bertassello, et al.Journal of the American Chemical Society|December 10, 2025
Enzyme-Activatable CXCL13 Chemokine Probes Enable Direct Fluorescence Detection of Hypoxic Subpopulations of Human B CellsMarco Bertolini, Kohei Iijima, Utsa Karmakar, et al.British Journal of Haematology|November 28, 2008
Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromesDario Ferrero, Antonella Darbesio, Valentina Giai, et al.Acta Haematologica|May 17, 2022
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of LiteratureGiulia Arrigo, Stefano D'Ardìa, Ernesta Audisio, et al.Cancers|February 25, 2023
Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center AnalysisSemra Aydin, Roberto Passera, Marco Cerrano, et al.Annals of Hematology|April 8, 2014
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Elena Crisà, Filippo Marmont, et al.Annals of Hematology|February 11, 2010
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Ermanno Venturino, Roberto Passera, et al.Pageof 5